Active, not recruiting
A Phase I/II, Dose-finding Study to Assess the Safety, Reactogenicity, and Immunogenicity of a Broadly Protective Sarbecovirus Vaccine (GBP511) in Healthy Adults.
NCT07280858
- Conditions
- Healthy Participants, Sarbecovirus
- Locations
-
- Momentum Clinical Research Darlinghurst Sydney, Kent Street, Australia
- Linear Nedlands, Western Australia, Australia
- Linear Joondalup, Western Australia, Australia